GC Cell Corporation (KOSDAQ: A144510)
Health Care · Biotechnology · KR
₩14,600.00
+0.14% today · -26.8% 1Y
GC Cell Corporation (KOSDAQ: A144510) operates in the Biotechnology industry within the Health Care sector. The company is valued at $163.20M.
Over the last twelve months the share price has lost 26.8%, trading between 11.61K and 28.45K.
Tweenvest scores GC Cell Corporation across four factors: quality 57/100, value 57/100. Its strongest factor is quality.
A144510 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $163.20M
- Revenue (TTM)
- $104.61M
- P/E
- —
- EPS
- -16,396.74
- Dividend yield
- —
- Beta (5Y)
- 0.57
- 52-week high
- ₩28,450.00
- 52-week low
- ₩11,610.00
- Avg volume (3M)
- —
- Shares outstanding
- 15.03M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Medigen Biotechnology Corp.TPEX: 3176 | $168.61M | NT$— | — |
| Canton Strategic Holdings, Inc.NasdaqCM: CNTN | $168.13M | $2.11 | 0.00% |
| AptaBio Therapeutics Inc.KOSDAQ: A293780 | $165.92M | ₩7,940.00 | +1.79% |
| Burning Rock Biotech LimitedNasdaqGM: BNR | $163.36M | $15.00 | -3.16% |
| Protara Therapeutics, Inc.NasdaqGM: TARA | $162.81M | $2.77 | +0.54% |
| Bioneer CorporationKOSDAQ: A064550 | $162.42M | ₩8,460.00 | -1.28% |
| Nkarta, Inc.NasdaqGS: NKTX | $161.16M | $2.17 | -3.56% |
| curacle co.,ltd.KOSDAQ: A365270 | $161.02M | ₩9,770.00 | -4.22% |
Figures last refreshed Oct 11, 2026.